1 Auerbach S, "placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia" 1467-74, jurol1992;148
2 "immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3" 885 243-1989 7,
3 "de la Rosette JJMCH. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostate hyperplasia. J Urol 1996" 1959-64
4 "Winfield HN. Relationship of symptoms of prostatism to commonly physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993" 351-8,
5 "Wennberg JE. Transurethral resection of the prostate among Medicare beneficiaries in the United States" 692-8, .urology1994
6 Barry MJ, "Transurethral resection of the prostate among Medicare beneficiaries in the United States" 692-8, urology1994;44
7 "The effect of subjective urinary symptoms on quality of life: results of a field survey for prostatic disease" 1248-55,
8 Tsukamoto T, "The effect of subjective urinary symptoms on quality of life results of a field survey for prostatic disease" 1248-55, nipponhinyokikagakkaizasshi1994;85
9 Bosch JL, "The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume" 75 : 622-630, 1995
10 "The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume" 75 : 622-630, 1995
1 Auerbach S, "placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia" 1467-74, jurol1992;148
2 "immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3" 885 243-1989 7,
3 "de la Rosette JJMCH. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostate hyperplasia. J Urol 1996" 1959-64
4 "Winfield HN. Relationship of symptoms of prostatism to commonly physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993" 351-8,
5 "Wennberg JE. Transurethral resection of the prostate among Medicare beneficiaries in the United States" 692-8, .urology1994
6 Barry MJ, "Transurethral resection of the prostate among Medicare beneficiaries in the United States" 692-8, urology1994;44
7 "The effect of subjective urinary symptoms on quality of life: results of a field survey for prostatic disease" 1248-55,
8 Tsukamoto T, "The effect of subjective urinary symptoms on quality of life results of a field survey for prostatic disease" 1248-55, nipponhinyokikagakkaizasshi1994;85
9 Bosch JL, "The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume" 75 : 622-630, 1995
10 "The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume" 75 : 622-630, 1995
11 "The International Continence Society "Benign Prostatic Hyperplasia" Study: L international differences in lower urinary tract symptoms and related bother" 157 : 1295-1300, 1997
12 Witjes WP, "The International Continence Society "Benign Prostatic Hyperplasia" Study: L international differences in lower urinary tract symptoms and related bother" 157 : 1295-1300, 1997
13 "The International Continence Society 'Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms" 157 : 885-889, 1997
14 Peters TJ, "The International Continence Society 'Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms" 157 : 885-889, 1997
15 "The ICS-'BPH' study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction" 82 : 619-623, 1998
16 Reynard JM, "The ICS-'BPH' study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction" 82 : 619-623, 1998
17 "The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association" 1549-57,
18 Berry MJ, "The American Urological Association symptom index for benign prostatic hyperplasia The Measurement Committee of the American Urological Association" 1549-57, jurol1992;148
19 "Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia" 57 : 695-700, 2001
20 Eckhardt MD, "Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia" 57 : 695-700, 2001
21 Din KEE, "Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostate hyperplasia" 155 : 1959-1964, 1996
22 Barry MJ, "Relationship of symptoms of prostatism to commonly physiological and anatomical measures of the severity of benign prostatic hyperplasia" 351-8, jurol1993;150
23 "National Health Insurance Yearly book 20th, 21th, 22th, 23th edition" National health insurance cooperation
24 "Medical therapy for benign prostatic hyperplasia: a review of the literature" 38 : 2-19, 2000
25 Cifford GM, "Medical therapy for benign prostatic hyperplasia: a review of the literature" 38 : 2-19, 2000
26 "Impact of symptoms of prostatism on level of bother and quality of life of men in the French community" 153 : 669-673, 1995
27 Sagnier PP, "Impact of symptoms of prostatism on level of bother and quality of life of men in the French community" 153 : 669-673, 1995
28 Perrin P, "Forty years of transurethral prostatic resections" 757-8, jurol1976;116
29 Barry MJ, "Epidemiology and natural history of benign prostatic hyperplasia" 495-507,
30 "Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China" 113 : 299-302, 2000
31 "Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China" 113 : 299-302, 2000
32 Ezz el Din K, "Correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the International Prostate Symptom Score" 48 : 393-397, 1996
33 "Correlation between uroflowmetry, prostate volume, postvoid residue and lower urinary tract symptoms as measured by the International Prostate Symptom Score" 48 : 393-397, 1996
34 Reynard JM, "Bladder-outlet obstruction-assessment of symptoms" 13 : 3-8, 1995
35 "Bladder-outlet obstruction-assessment of symptoms" 13 : 3-8, 1995
36 "Bergman RT. Forty years of transurethral prostatic resections. J Urol 1976" 757-8,
37 "Benign prostatic hyperplasia" 361 : 1359-1367, 2003
38 Thorpe A, "Benign prostatic hyperplasia" 361 : 1359-1367, 2003
39 "Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1990" 495-507,
40 "A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia" 1467-74,
41 Van Melick HH, "A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality" 169 : 1411-1416, 2003
42 "A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality" 169 : 1411-1416, 2003
43 Holtgrewe HL, "A cooperative study of 13 participating institutions evaluating 3" 885 243-7, jurol1989;141